Triatec 1

Triatec 1 is a medicine authorised by Swissmedic under authorisation number 53875. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 1996 and the authorisation is valid without a time limit. ATC code C09AA05 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 53875
  • ATC C09AA05
  • Synthetic medicines
Authorisation data
Authorisation number53875
NameTriatec 1
Full nameTriatec 1,25 mg, comprimés
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09AA05
First authorisation16 December 1996
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Triatec 1,25 mg, comprimésB16 December 1996
2Triatec 2,5 mg, comprimésB16 December 1996
3Triatec 5 mg, comprimésB16 December 1996
4Triatec 10 mg, comprimésB16 December 1996

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
10620Tablette(n)C09AA0502.07.1.B
114100Tablette(n)C09AA0502.07.1.B
12220Tablette(n)C09AA0502.07.1.B
130100Tablette(n)C09AA0502.07.1.B
14920Tablette(n)C09AA0502.07.1.B
157100Tablette(n)C09AA0502.07.1.B
8420Tablette(n)C09AA0502.07.1.B
92100Tablette(n)C09AA0502.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Triatec 1 authorised in Switzerland?

Yes. Triatec 1 is authorised by Swissmedic under authorisation number 53875, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Triatec 1 have?

Triatec 1 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Triatec 1?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com